/Investor DB

Domain Associates — 2020 Investments

5 investments dated 2020 · listed companies and verified rows first · show all

Evofem BiosciencesinOTC: EVFMApr 2020SEC filingmedium confidence

Evofem Biosciences is a biopharmaceutical company that commercializes products for women's sexual and reproductive health, including PHEXX, a non-hormonal prescription vaginal contraceptive gel applied before intercourse, and SOLOSEC, an oral antimicrobial agent for treating bacterial vaginosis and trichomoniasis.

BiotechSan Diego, US

Ivy Zhang(Executive Officer)inSaundra Pelletier(Executive Officer, Director)inKelly Culwell(Executive Officer)inJustin J. File(Executive Officer)inAlexander A. Fitzpatrick(Executive Officer)Russell Barrans(Executive Officer)

Board seatKim Kamdar· per SEC Form D · $25M raise · filed May 2020

Co-investorsAdjuvant CapitalInvescoWoodford Investment Management

Aspen Neuroscienceaspenneuroscience.comin𝕏Apr 2020 · $70M✓ verified

Aspen Neuroscience develops iPSC-derived autologous cell therapies for neurological diseases, with a lead product (ANPD001) in Phase 1/2a clinical trials for Parkinson's disease.

BiotechDeep TechDigital HealthMedical DevicesSan Diego, US

Andrés Bratt-Leal(Co-Founder and Senior Vice President, Research & Development)inANDRÉS BRATT-LEAL, Ph.D.(Co-Founder; Senior Vice President, Research & Development)Damien McDevitt(President and Chief Executive Officer)inDAMIEN MCDEVITT, Ph.D.(President and Chief Executive Officer)

Co-investorsARCH Venture PartnersLifeforce CapitalOrbiMedEDB InvestmentsSection 32Frazier Life Sciences+10 more

Omniomeomniome.comJan 2020 · $60MAcquired

San Diego DNA sequencing company behind the Sequencing by Binding short-read platform; acquired by Pacific Biosciences in 2021.

BiotechSan Diego, US

David S. Mullarkey(Executive Officer, Director)Arnold Oliphant(Executive Officer)inKen Song, M.D., Ph.D.(Executive Officer, Director)Kelly Perez(Executive Officer)John Murphy, Ph.D.(Executive Officer)Millard Y Chan(Chief Operating Officer, Secretary and Director)

Co-investorsARCH Venture PartnersATEL VenturesDCVC (Data Collective)Decheng CapitalLam CapitalPivotal Life Sciences+3 more

Signifier Medical Technologiessignifiermedical.comSeries C · Sep 2020 · $10M

Signifier Medical Technologies is a medical device company developing non-invasive treatments for snoring and mild sleep apnea.

Digital HealthMedical DevicesWellness & Fitness

Akhil Tripathi(Co-founder)Phil Radford(Chairman)John Saville Bentley(Chief Executive Officer)Thomas McCarthy(Chief Financial Officer)

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Exalys Therapeutics

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.